MENU
SABS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

SAB Biotherapeutics (SABS) Earnings Date & Reports

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum... Show more

A.I. Advisor
published Earnings

SABS is expected to report earnings to rise 48.80% to -83 cents per share on March 28

SAB Biotherapeutics SABS Stock Earnings Reports
Q4'23
Est.
$-0.83
Q1'25
Missed
by $0.44
Q3'23
Missed
by $0.88
Q2'23
Missed
by $1.26
Q1'23
Missed
by $1.39
The last earnings report on May 09 showed earnings per share of -56 cents, missing the estimate of -11 cents. With 2.93K shares outstanding, the current market capitalization sits at 17.05M.
View a ticker or compare two or three
SABS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2100 East 54th Street North
Phone
+1 605 679-6980
Employees
57
Web
https://www.sabbiotherapeutics.com